Point72 Italy S.r.l. acquired a new position in shares of Teradyne, Inc. (NASDAQ:TER - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 170,776 shares of the company's stock, valued at approximately $21,504,000. Teradyne comprises 11.9% of Point72 Italy S.r.l.'s portfolio, making the stock its 2nd largest holding. Point72 Italy S.r.l. owned 0.10% of Teradyne at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Compass Financial Services Inc acquired a new stake in shares of Teradyne in the fourth quarter valued at approximately $33,000. Strategic Investment Solutions Inc. IL acquired a new stake in shares of Teradyne in the fourth quarter valued at approximately $34,000. AllSquare Wealth Management LLC raised its position in shares of Teradyne by 200.0% in the fourth quarter. AllSquare Wealth Management LLC now owns 300 shares of the company's stock valued at $38,000 after buying an additional 200 shares in the last quarter. Manchester Capital Management LLC raised its position in Teradyne by 264.0% during the fourth quarter. Manchester Capital Management LLC now owns 313 shares of the company's stock valued at $39,000 after purchasing an additional 227 shares in the last quarter. Finally, Murphy & Mullick Capital Management Corp acquired a new position in Teradyne during the fourth quarter valued at approximately $45,000. 99.77% of the stock is currently owned by institutional investors and hedge funds.
Teradyne Price Performance
Shares of Teradyne stock traded down $0.26 during trading on Friday, hitting $82.73. The company's stock had a trading volume of 2,181,891 shares, compared to its average volume of 2,598,353. Teradyne, Inc. has a 52 week low of $65.77 and a 52 week high of $163.21. The stock has a market cap of $13.27 billion, a price-to-earnings ratio of 24.84, a price-to-earnings-growth ratio of 2.83 and a beta of 1.70. The stock has a 50-day moving average price of $78.97 and a two-hundred day moving average price of $104.31.
Teradyne (NASDAQ:TER - Get Free Report) last issued its quarterly earnings data on Monday, April 28th. The company reported $0.75 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.14. Teradyne had a net margin of 19.23% and a return on equity of 19.08%. The company had revenue of $685.70 million for the quarter, compared to analysts' expectations of $680.54 million. During the same quarter in the previous year, the firm posted $0.51 earnings per share. Teradyne's revenue for the quarter was up 14.3% on a year-over-year basis. On average, equities analysts predict that Teradyne, Inc. will post 3.88 EPS for the current fiscal year.
Teradyne Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Thursday, May 22nd will be given a dividend of $0.12 per share. The ex-dividend date is Thursday, May 22nd. This represents a $0.48 dividend on an annualized basis and a yield of 0.58%. Teradyne's dividend payout ratio (DPR) is currently 13.56%.
Teradyne announced that its Board of Directors has approved a share buyback plan on Monday, April 28th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 8.1% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its stock is undervalued.
Analyst Upgrades and Downgrades
Several research analysts have commented on TER shares. Northland Securities lowered their price objective on shares of Teradyne from $154.00 to $140.00 and set an "outperform" rating for the company in a research report on Friday, January 31st. Morgan Stanley lowered their price objective on shares of Teradyne from $81.00 to $69.00 and set an "underweight" rating for the company in a research report on Wednesday, April 16th. Susquehanna lowered their price objective on shares of Teradyne from $155.00 to $133.00 and set a "positive" rating for the company in a research report on Wednesday, April 30th. Citigroup lowered their price objective on shares of Teradyne from $130.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, March 12th. Finally, Vertical Research started coverage on shares of Teradyne in a research report on Friday, March 7th. They set a "buy" rating and a $135.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Teradyne currently has a consensus rating of "Moderate Buy" and a consensus price target of $117.56.
Read Our Latest Stock Report on TER
Teradyne Profile
(
Free Report)
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Featured Articles

Before you consider Teradyne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teradyne wasn't on the list.
While Teradyne currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.